MedTrace Logo

Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer

NCT06072911 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2026-01-30

No results posted yet for this study

Summary

The Continence, Sexual and Metabolic Health (CONTROL 4 LIFE) study will evaluate the recovery of continence, sexual function, and health outcomes in individuals who have undergone surgery for prostate cancer. The purpose of this study is to better understand the timelines of recovery for these outcomes after surgery for prostate cancer. As part of this study, all participants will receive resources offered by Alberta Health Services regarding pre- and post-prostatectomy care, including information on pelvic floor exercises. Through the CONTROL 4 LIFE study, the investigators will also be evaluating outcomes related to physical activity, fitness and quality of life. These assessments will enable the investigators to better understand how well and how long it takes for individuals to recover after surgery for prostate cancer.

Conditions

Interventions

BEHAVIORAL

Pelvic floor exercise program

General exercises will be prescribed along with a specialized pelvic floor program

BEHAVIORAL

General exercise

A general progressive resistance exercise program

BEHAVIORAL

Physical Activity Counseling

Advice on increasing physical activity

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Nathan Hoy, MD · University of Alberta

  • Howard Evans, MD · University of Alberta

  • Margaret McNeely · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-27
Primary Completion
2026-04-30
Completion
2026-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06072911 on ClinicalTrials.gov